PAVmed
PAVM on Nasdaq. Market value $13m.
Should I look at this?
Look carefully before going further
Why it could be worth it
Nothing stands out yet.
What to watch out for
Read the warning sign in its own filings
This is not advice.
Who owns it
1 long-term investor we follow owns it, unchanged from 1 last quarter. 20 funds in all.
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| First Manhattan Co.First Manhattan partners | $2m | <0.1% | Added |
Largest holders overall
- Two Seas Capital LP$3m
- First Manhattan Co.$2mAdded
- Vanguard Capital Management$365,928Added
- Geode Capital Management$217,871Added
- Vanguard Fiduciary Trust$152,094Added
- BlackRock$101,526Added
- Morgan Stanley$968
- Barclays$446New
- SBI Securities$398
- UBS Group AG$339Cut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
10 investors own more than 5%.
- Dana CarreraPassive investorat least 15.3%+1.0 pts(filed with 1 related holder)Since 27 March 2026
- Two Seas Capital LPPassive investorat least 10.0%(filed with 2 related holders)Since 31 March 2026
- Ayrton Capital LLCPassive investorat least 10.0%+0.1 pts(filed with 2 related holders)Since 31 March 2026
- Scopia Holdings LLCPassive investorat least 9.9%(filed with 1 related holder)Since 27 March 2026
- First Manhattan Co.Passive investorat least 9.6%+5.3 pts(filed with 2 related holders)Since 31 March 2026
- NAGELBERG DAVID SPassive investorat least 8.8%+0.2 pts(filed with 1 related holder)Since 30 June 2026
- Dols Scott V.Passive investor5.8%+0.4 ptsSince 30 September 2026
- Sargent Investment Group, LLCPassive investor5.8%Since 1 July 2025
- Aklog LishanInsider or founder5.1%Since 2 April 2026
What they said
Dr. Aklog acquired beneficial ownership of the shares of Common Stock described in this Schedule 13D for investment purposes. Dr. Aklog may from time to time acquire beneficial ownership of additional securities for investment purposes, or dispose of securities, in the open…
Read the filing - Kallman CraigPassive investorat least 4.9%−1.1 pts(filed with 1 related holder)Since 30 September 2026
| Holder | Stake | Since | |
|---|---|---|---|
Dana Carrera Passive investor | at least 15.3%+1.0 pts (filed with 1 related holder) | 27 March 2026 | |
Two Seas Capital LP Passive investor | at least 10.0% (filed with 2 related holders) | 31 March 2026 | |
Ayrton Capital LLC Passive investor | at least 10.0%+0.1 pts (filed with 2 related holders) | 31 March 2026 | |
Scopia Holdings LLC Passive investor | at least 9.9% (filed with 1 related holder) | 27 March 2026 | |
First Manhattan Co. Passive investor | at least 9.6%+5.3 pts (filed with 2 related holders) | 31 March 2026 | |
NAGELBERG DAVID S Passive investor | at least 8.8%+0.2 pts (filed with 1 related holder) | 30 June 2026 | |
Dols Scott V. Passive investor | 5.8%+0.4 pts | 30 September 2026 | |
Sargent Investment Group, LLC Passive investor | 5.8% | 1 July 2025 | |
Aklog Lishan Insider or founder | 5.1% | 2 April 2026 | What they saidDr. Aklog acquired beneficial ownership of the shares of Common Stock described in this Schedule 13D for investment purposes. Dr. Aklog may from time to time acquire beneficial ownership of additional securities for investment purposes, or dispose of securities, in the open… Read the filing |
Kallman Craig Passive investor | at least 4.9%−1.1 pts (filed with 1 related holder) | 30 September 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought or sold on the open market in the last 12 months.
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
2 serious warning signs in PAVmed’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 27 Mar 2026, plus the 10-Q filed 16 Nov 2026 and 7 later 8-Ks.
Doubt it can keep going
SeriousThe company or its auditor warned it may not have enough money to last the next year.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”
Show the full paragraph
The Company’s ability to continue operations 12 months beyond the issuance of the financial statements will depend upon its ability to control its operating costs within the limits of the amounts collected from its management service contracts with its non-consolidated subsidiaries, to substantially increase its revenues from the Veris Cancer Care Platform, and to raise additional capital through various potential sources including equity or debt financings, the exercise of outstanding warrants by the holders thereof or refinancing or restructuring existing debt obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.
From the 10-Q filed 16 November 2026, Part I, Item 1. Financial Statements. Read it in the filing
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.
“Based on such evaluation, our principal executive officer and principal financial officer concluded, because of the material weakness in our internal control over financial reporting described below, that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective as of such date to provide reasonable assurance the information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.”
Show the full paragraph
Our management, with the participation of our principal executive officer and our principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026. Based on such evaluation, our principal executive officer and principal financial officer concluded, because of the material weakness in our internal control over financial reporting described below, that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective as of such date to provide reasonable assurance the information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
From the 10-Q filed 16 November 2026, Part I, Item 4. Controls and Procedures. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.